期刊论文

中文

北京中医药大学学报

1006-2157

2024

47

3

394-406

10.3969/j.issn.1006-2157.2024.03.014

本校为第一机构

目的 探讨鳖甲煎丸通过miR-885-5p对表皮生长因子受体(EGFR)/丝裂原激活蛋白激酶(MAPK)/细胞外信号调节激酶(ERK)信号通路的靶向调控对MHCC-97H肝癌细胞的影响及作用机制.方法 SPF级SD大鼠10只随意分为空白组和鳖甲煎丸(1.1 g/kg)组,制备空白及鳖甲煎丸含药血清.取对数生长期的MHCC-97H细胞,分为模型组、不同质量分数(5％、10％、15％、20％)空白血清梯度组和鳖甲煎丸含药血清梯度组,以及不含细胞的空白组.CCK-8法检测细胞增殖,筛选含药血清最佳干预时间及质量分数.将MHCC-97H细胞分为空白对照组(不做任何处理)、鳖甲煎丸含药血清组(20％鳖甲煎丸含药血清)、miR-885-5p mimics组(转染miR-885-5p...

Objective We aimed to investigate the effects of Biejiajian Pills on MHCC-97H hepatoma cells and whether Biejiajian Pills regulate the epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling pathway through miR-885-5p.Methods SPF SD rats (n = 10) were randomly divided into the blank group and the Biejiajian Pills (1.1 g/kg) group to prepare blank and Biejiajian Pills-containing serum. MHCC-97H cells in the logarithmic growth phase were divided into the model group, bl...